Latest News & Updates
Breaking News
1 day ago
Vaibhavi M.
Other trending news you may like to read
Medicus Pharma Gains UK Approval to Expand Phase 2 Trial Of Doxorubicin Microneedle Therapy for Basal Cell Carcinoma
Medicus Pharma secures UK approvals to expand its Phase 2 trial of its non-invasive Doxorubicin Microneedle Array for treating basal cell carcinoma.
Vaibhavi M.
ORIC Pharmaceuticals Shares Positive Phase 1b Data For ORIC-944 in Combination With AR Inhibitors In mCRPC
ORIC reports promising Phase 1b results for ORIC-944 in mCRPC, showing strong tolerability and early efficacy in combination with AR inhibitors.
Vaibhavi M.
MHRA Approves Eisai And Biogen’s LEQEMBI® For Once-Monthly Maintenance Dosing in Early Alzheimer’s Disease
UK MHRA approves LEQEMBI for once-every-four-weeks maintenance dosing, offering Alzheimer’s patients greater long-term treatment flexibility.
Vaibhavi M.
Amneal Secures FDA Approval for First Generic Iohexol Injection A Generic Radiographic Contrast Agent Ahead Of 2026 Launch; Challenging Omnipaque® Market
FDA approves Amneal’s iohexol injection, the first generic Omnipaque®, expanding access to a key radiographic contrast agent.
Vaibhavi M.
